TTPH - Tetraphase Pharmaceuticals Inc.
Previous close
2.2
0 0%
Share volume: 0
Last Updated: Tue 28 Jul 2020 06:00:00 AM CEST
Pharmaceuticals: Other:
0%
PREVIOUS CLOSE
CHG
CHG%
$2.20
0.00
0.00%
Summary score
12%
Profitability
0%
Dept financing
9%
Liquidity
52%
Performance
15%
Sector
Health Technology
Industry
Pharmaceuticals: Other
Long-term ratios 2016 - 2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-29.15%
Return on assets
-20.44%
Return on sales
-948.81%
Return on invested capital
-152.27%
Total debt ratio
22.32%
Debt ratio change over timeo
-0.92%
Current Ratio
7.49%
Quick Ratio
4.56%
Cash Position Ratio
6.93%
Short-term ratios 2019 - 2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-52.35%
Return on assets
-30.24%
Return on sales
-924.45%
Return on invested capital
-1478.32%
Total debt ratio
38.38%
Debt ratio change over timeo
-0.95%
Current Ratio
3.29%
Quick Ratio
3.14%
Cash Position Ratio
2.79%
Last quarter ratios 2020
The data are presented for the financials results of the last quarter.
Return on equity
-44.16%
Return on assets
-32.83%
Return on sales
-698.8%
Return on invested capital
1990.8%
Total debt ratio
26.5%
Debt ratio change over time
-1%
Current Ratio
3.66%
Quick Ratio
3.56%
Cash Position Ratio
3.21%
Performance ratios (change over 4 years) 2016 - 2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-110.64%
Return on assets
-108.28%
Return on sales
-282.49%
Return on invested capital
-11.33%
Total debt ratio
-91.98%
Debt ratio change over time
-0.92%
Current Ratio
2.63%
Quick Ratio
0.19%
Cash Position Ratio
2.36%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
Long-term ratios | TTPH | MYOK | MDCO | ARQL |
---|---|---|---|---|
Return on equity | -29.15% | -7.13% | -82.7% | -27.35% |
Return on assets | -20.44% | -6.36% | -6.39% | -11.35% |
Return on sales | -948.81% | 0% | -592.81% | 0% |
Return on invested capital | -152.27% | -84.69% | -39.78% | 65.52% |
Profitability | 0% | 75% | 0% | 25% |
Total debt ratio | 22.32% | 15.45% | 89.22% | 38.11% |
Debt ratio change over time | -0.92% | -0.99% | -8.16% | -0.59% |
Dept financing | 6% | 4% | 25% | 36% |
Current Ratio | 3.29% | 11.45% | 3.37% | 10.41% |
Quick Ratio | 3.14% | 0% | 0% | 0% |
Cash Position Ratio | 2.79% | 6.31% | 2.81% | 5.11% |
Liquididy | 72% | 48% | 30% | 27% |
Short-term ratios | TTPH | MYOK | MDCO | ARQL |
---|---|---|---|---|
Return on equity | -52.35% | -13.67% | -16.61% | -6.32% |
Return on assets | -30.24% | -12.16% | -6.02% | -5.59% |
Return on sales | -924.45% | 0% | 0% | 0% |
Return on invested capital | -1478.32% | 4.61% | -30.98% | 34.2% |
Profitability | 0% | 3% | 25% | 75% |
Total debt ratio | 38.38% | 12.33% | 101.32% | 14.38% |
Debt ratio change over time | -0.95% | -1.02% | -9.66% | -0.83% |
Dept financing | 9% | 3% | 25% | 29% |
Current Ratio | 3.29% | 11.45% | 3.37% | 10.41% |
Quick Ratio | 3.14% | 0% | 0% | 0% |
Cash Position Ratio | 2.79% | 6.31% | 2.81% | 5.11% |
Liquididy | 43% | 50% | 18% | 43% |